Veriko Mirtskhulava

773 total citations
17 papers, 551 citations indexed

About

Veriko Mirtskhulava is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Veriko Mirtskhulava has authored 17 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 12 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Veriko Mirtskhulava's work include Tuberculosis Research and Epidemiology (16 papers), Pneumonia and Respiratory Infections (7 papers) and Diagnosis and treatment of tuberculosis (6 papers). Veriko Mirtskhulava is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Pneumonia and Respiratory Infections (7 papers) and Diagnosis and treatment of tuberculosis (6 papers). Veriko Mirtskhulava collaborates with scholars based in Georgia, United States and Netherlands. Veriko Mirtskhulava's co-authors include Henry M. Blumberg, Russell R. Kempker, Maia Kipiani, Archil Salakaia, Nino Lomtadze, Nestani Tukvadze, Matthew J. Magee, Rusudan Aspindzelashvili, A Wright and Carlos del Rı́o and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Clinical Infectious Diseases.

In The Last Decade

Veriko Mirtskhulava

15 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veriko Mirtskhulava Georgia 11 448 323 167 84 56 17 551
Rosa Yataco United States 14 402 0.9× 320 1.0× 133 0.8× 15 0.2× 47 0.8× 33 511
Chishala Chabala Zambia 10 303 0.7× 237 0.7× 130 0.8× 25 0.3× 42 0.8× 31 436
Yasmeen Hanifa United Kingdom 12 289 0.6× 229 0.7× 116 0.7× 23 0.3× 17 0.3× 17 395
Tesfaye Madebo Norway 10 162 0.4× 171 0.5× 97 0.6× 17 0.2× 56 1.0× 31 428
Belete Achamyelew Ayele Ethiopia 12 162 0.4× 128 0.4× 58 0.3× 18 0.2× 101 1.8× 21 408
Gil Lavie Israel 10 233 0.5× 118 0.4× 55 0.3× 18 0.2× 25 0.4× 29 512
Cho‐Yu Chan Taiwan 17 116 0.3× 633 2.0× 102 0.6× 23 0.3× 15 0.3× 50 993
C. C. Leung China 6 187 0.4× 152 0.5× 84 0.5× 13 0.2× 15 0.3× 6 344
Jesús Oliva Spain 12 206 0.5× 245 0.8× 35 0.2× 50 0.6× 12 0.2× 26 482
Ghali Iraqi Morocco 7 207 0.5× 183 0.6× 70 0.4× 21 0.3× 9 0.2× 14 440

Countries citing papers authored by Veriko Mirtskhulava

Since Specialization
Citations

This map shows the geographic impact of Veriko Mirtskhulava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veriko Mirtskhulava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veriko Mirtskhulava more than expected).

Fields of papers citing papers by Veriko Mirtskhulava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veriko Mirtskhulava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veriko Mirtskhulava. The network helps show where Veriko Mirtskhulava may publish in the future.

Co-authorship network of co-authors of Veriko Mirtskhulava

This figure shows the co-authorship network connecting the top 25 collaborators of Veriko Mirtskhulava. A scholar is included among the top collaborators of Veriko Mirtskhulava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veriko Mirtskhulava. Veriko Mirtskhulava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wares, D. F., et al.. (2024). Experiences in the introduction of bedaquiline pretomanid linezolid for drug-resistant tuberculosis in Kyrgyzstan. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 36. 100472–100472.
2.
Nguyen, Hai Viet, Petra de Haas, Hoa Binh Nguyen, et al.. (2022). Discordant results of Xpert MTB/Rif assay and BACTEC MGIT 960 liquid culture to detect Mycobacterium tuberculosis in community screening in Vietnam. BMC Infectious Diseases. 22(1). 506–506. 4 indexed citations
3.
Kipiani, Maia, et al.. (2021). Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis. Open Forum Infectious Diseases. 8(12). ofab551–ofab551. 2 indexed citations
4.
Nguyen, Hai Viet, Hoa Binh Nguyen, Nguyen Viet Nhung, et al.. (2021). Decline of Tuberculosis Burden in Vietnam Measured by Consecutive National Surveys, 2007–2017. Emerging infectious diseases. 27(3). 872–879.
5.
Nguyen, Hai Viet, Hoa Binh Nguyen, Nguyen Viet Nhung, et al.. (2021). Decline of Tuberculosis Burden in Vietnam Measured by Consecutive National Surveys, 2007–2017. Emerging infectious diseases. 27(3). 872–879. 6 indexed citations
6.
Nguyen, Hai Viet, Hai Viet Nguyen, Edine Tiemersma, et al.. (2020). The second national tuberculosis prevalence survey in Vietnam. PLoS ONE. 15(4). e0232142–e0232142. 45 indexed citations
7.
Mirtskhulava, Veriko, Maia Kipiani, Henry M. Blumberg, et al.. (2019). Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, Georgia. The International Journal of Tuberculosis and Lung Disease. 23(9). 1005–1011. 8 indexed citations
8.
Hof, Susan van den, et al.. (2019). Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in Tajikistan. The International Journal of Tuberculosis and Lung Disease. 23(3). 331–336. 17 indexed citations
9.
Kipiani, Maia, Gautam Hebbar, Kirk A. Easley, et al.. (2015). High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial. American Journal of Clinical Nutrition. 102(5). 1059–1069. 100 indexed citations
10.
Mirtskhulava, Veriko, Jennifer A. Whitaker, Maia Kipiani, et al.. (2015). Determinants of Tuberculosis Infection Control–Related Behaviors Among Healthcare Workers in the Country of Georgia. Infection Control and Hospital Epidemiology. 36(5). 522–528. 21 indexed citations
11.
Kempker, Russell R., Maia Kipiani, Veriko Mirtskhulava, et al.. (2015). Acquired Drug Resistance inMycobacterium tuberculosisand Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis. Emerging infectious diseases. 21(6). 992–1001. 55 indexed citations
12.
Kipiani, Maia, Veriko Mirtskhulava, Nestani Tukvadze, et al.. (2014). Significant Clinical Impact of a Rapid Molecular Diagnostic Test (Genotype MTBDRplus Assay) to Detect Multidrug-Resistant Tuberculosis. Clinical Infectious Diseases. 59(11). 1559–1566. 37 indexed citations
13.
Whitaker, Jennifer A., Veriko Mirtskhulava, Maia Kipiani, et al.. (2013). Correction: Prevalence and Incidence of Latent Tuberculosis Infection in Georgian Healthcare Workers. PLoS ONE. 8(6). 11 indexed citations
14.
Whitaker, Jennifer A., Veriko Mirtskhulava, Maia Kipiani, et al.. (2013). Prevalence and Incidence of Latent Tuberculosis Infection in Georgian Healthcare Workers. PLoS ONE. 8(3). e58202–e58202. 45 indexed citations
15.
Tukvadze, Nestani, Jennifer K. Frediani, Maia Kipiani, et al.. (2012). Effects of sunlight and diet on vitamin D status of pulmonary tuberculosis patients in Tbilisi, Georgia. Nutrition. 28(4). 362–366. 34 indexed citations
16.
Lomtadze, Nino, et al.. (2009). Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study.. PubMed. 13(1). 68–73. 107 indexed citations
17.
Mirtskhulava, Veriko, Russell R. Kempker, Michael Leonard, et al.. (2008). Prevalence and risk factors for latent tuberculosis infection among health care workers in Georgia.. PubMed. 12(5). 513–9. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa Yataco Breakdown of academic impact, for papers by Chishala Chabala Breakdown of academic impact, for papers by Yasmeen Hanifa Breakdown of academic impact, for papers by Tesfaye Madebo Breakdown of academic impact, for papers by Belete Achamyelew Ayele Breakdown of academic impact, for papers by Gil Lavie Breakdown of academic impact, for papers by Cho‐Yu Chan Breakdown of academic impact, for papers by C. C. Leung Breakdown of academic impact, for papers by Jesús Oliva Breakdown of academic impact, for papers by Ghali Iraqi
Rankless by CCL
2026